<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01943253</url>
  </required_header>
  <id_info>
    <org_study_id>Hybrid ESD</org_study_id>
    <nct_id>NCT01943253</nct_id>
  </id_info>
  <brief_title>Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer</brief_title>
  <official_title>Water-jet Assisted Endoscopic Submucosal Dissection (ESD) in Comparison to Conventional ESD Technique for Treatment of Early Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Evangelisches Krankenhaus Düsseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Introduction The aim of the study is to evaluate the efficacy and safety of ESD by use
           of a new water-jet assisted ESD system using the HybridKnife® in patients with early
           gastric neoplastic lesions in comparison to the conventional ESD established in Japan.
           The water-assisted ESD technology allows pressure controlled injection of fluids through
           the tip of a recently developed HybridKnife®. Submucosal injection, circumferential
           cutting and dissection of lesions as well as coagulation of bleeding can be performed
           with the same device without need for changing the instrument. These options should
           accelerate the procedure and may increase its safety and efficacy.

        2. Hypothesis The water-jet assisted ESD technique using the HybridKnife® bears the
           advantage of less instrument changes due to the combination of high-frequency cutting
           and water-jet application in one single instrument. This should lead to a simplified ESD
           procedure, shorter learn-ing curve and especially to a shorter procedure time.

      The water-jet assisted ESD technique should be shorter than the conventional ESD techniques
      using IT2-, Dual- and Hook-Knifes at least with the same safety and effectiveness.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedure time</measure>
    <time_frame>during procedure</time_frame>
    <description>The primary objective of the study is the procedure time of ESD using the conventional ESD technique in comparison to the water-jet assisted HybridKnife®-ESD technique.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>en bloc resection rate</measure>
    <time_frame>in procedure</time_frame>
    <description>Resection of the targeted lesion including coagulation markers in one piece.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>histological R0 rate</measure>
    <time_frame>7 days after procedure</time_frame>
    <description>En-bloc resection and histological confirmation of horizontal and vertical free margins of neoplasia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histologically incomplete resection</measure>
    <time_frame>7 days after procedure</time_frame>
    <description>Tumor infiltrated (R1) or undetermined (RX) margins of the resected specimen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedure related morbidity and mortality and complication rate</measure>
    <time_frame>30 days after procedure</time_frame>
    <description>procedure related morbidity and mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>30 days after procedure</time_frame>
    <description>any complication occurs after procedure within 30 days, such as bleeding or perforation rates</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Stomach Neoplasms</condition>
  <arm_group>
    <arm_group_label>Conventional ESD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional ESD: Conventional ESD technique using IT2-Knife, Dual-Knife, Hook-Knife (Olympus Europe, Hamburg, Germany) ERBE VIO 300D (V2.1.4) RF-surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany) Injection of fluid: Syringe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hybridknife ESD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2: Water-jet assisted HybridKnife® ESD technique using HybridKnife® (Erbe Elektromedizin GmbH, Tübingen, Germany) ERBE VIO 300D (V2.1.4) RF-surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany)
Injection of fluid: Integrated in HybridKnife® with ERBEJet 2 water-jet surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional ESD</intervention_name>
    <description>Conventional ESD: Conventional ESD technique using IT2-Knife, Dual-Knife, Hook-Knife (Olympus Europe, Hamburg, Germany; Olympus Japan) ERBE VIO 300D (V2.1.4) RF-surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany) Injection of fluid: Syringe</description>
    <arm_group_label>Conventional ESD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hybridknife ESD</intervention_name>
    <description>Group 2: Water-jet assisted HybridKnife® ESD technique using HybridKnife® (Erbe Elektromedizin GmbH, Tübingen, Germany) ERBE VIO 300D (V2.1.4) RF-surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany) Injection of fluid: Integrated in HybridKnife® with ERBEJet 2 water-jet surgery system (ERBE Elektromedizin GmbH, Tübingen, Germany)</description>
    <arm_group_label>Hybridknife ESD</arm_group_label>
    <other_name>Water-jet assisted HybridKnife® ESD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults (≥ 18 years) with confirmed diagnosis of gastric adenoma or early gastric
             adenocarcinoma

          -  differentiated mucosal adenocarinoma without ulcer findings ≤ 60 mm in diameter.

          -  Lesions with ulceration ≤ 30 mm in diameter.

          -  undifferentiated type of mucosal cancer is ≤ 20 mm.

          -  The patient has given written informed consent.

        Exclusion Criteria:

          -  pregnancy

          -  coagulopathy (INR&gt;2.0, platelets &lt; 70/nl)

          -  mucosal lesions which did not meet the inclusion criteria

          -  evidence of local or distant metastases according to endoscopic ultrasound (EUS)
             and/or CT scan, EUS (7.5 MHz probe) findings of tumor infiltration into deep layers of
             the submucosa or muscularis propria. -Patients unfit for deep sedation by use of
             propofol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Neuhaus</last_name>
    <role>Study Director</role>
    <affiliation>Evangelisches Krankenhaus Düsseldorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pinghong Zhou</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endoscopy Center, Zhongshan Hospital, Fudan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2013</study_first_submitted>
  <study_first_submitted_qc>September 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2013</study_first_posted>
  <last_update_submitted>September 11, 2013</last_update_submitted>
  <last_update_submitted_qc>September 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Early gastric cancer,</keyword>
  <keyword>endoscopic submucosal dissection (ESD)</keyword>
  <keyword>water-jet assisted ESD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

